# Risk Factors of Chinese Kidney Transplant Recipients DSA Based on MPA Immunosuppressive Regimen

> **NCT04444843** · PHASE4 · UNKNOWN · sponsor: **First Affiliated Hospital Xi'an Jiaotong University** · enrollment: 300 (estimated)

## Conditions studied

- Kidney Transplant Recipients

## Interventions

- **DRUG:** Mycophenolate Mofetil Capsules

## Key facts

- **NCT ID:** NCT04444843
- **Lead sponsor:** First Affiliated Hospital Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-22
- **Primary completion:** 2022-12-21
- **Final completion:** 2023-12-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2022-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04444843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04444843, "Risk Factors of Chinese Kidney Transplant Recipients DSA Based on MPA Immunosuppressive Regimen". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04444843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*